Ruxolitinib Impurity 7 | CAS 2606144-45-8 - Request Quote
Ruxolitinib Impurity 7
| SZ CAT No: | SZ-R044018 |
| CAS No | 2606144-45-8 |
| Mol.F. | C16H18N6O |
| Mol.Wt. | 310.4 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ruxolitinib Impurity 7 is chemically (R)-3-(4-(6-Amino-5-formylpyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile. Ruxolitinib Impurity 7 is supplied with detailed characterization data compliant with regulatory guideline. Ruxolitinib Impurity 7 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ruxolitinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2606144-45-8
Purchase 2606144-45-8
Order 2606144-45-8
Enquire 2606144-45-8
price of 2606144-45-8
2606144-45-8 Supplier
2606144-45-8 Manufacturer
2606144-45-8 Exporter
buy high quality Ruxolitinib Impurity 7
Purchase Ruxolitinib Impurity 7
Ruxolitinib Impurity 7 suppliers
Ruxolitinib Impurity 7 manufacturers
Ruxolitinib Impurity 7 price
Order Ruxolitinib Impurity 7
Enquire Ruxolitinib Impurity 7
Ruxolitinib Impurity 7 cost
Ruxolitinib Impurity 7 Supplier
Ruxolitinib Impurity 7 Distributor
Ruxolitinib Impurity 7 for Method Validation
Ruxolitinib Reference Standard
Ruxolitinib Impurity 7 for ANDA Filing
Ruxolitinib Impurity 7 for Forced Degradation Studies
Ruxolitinib Impurity 7 Identification Standards
Ruxolitinib Impurity 7 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.